![]() |
|
| Discuss Orchid chemicals at the Fundamental Analysis within the Traderji.com - Discussion forum for Stocks Commodities & Forex; Orchid was founded in 1992, with a focus on the manufacture of cephalosporin bulk drugs. ... |
|
|||||||
| Notices |
| Fundamental Analysis Discuss all about fundamental analysis and valuation. The world of PEs, free cash flow, ratio analysis, multiples and accounting numbers. |
![]() |
|
|
Thread Tools |
| Sponsored Links |
|
#1
|
|||
|
|||
|
Orchid was founded in 1992, with a focus on the manufacture of cephalosporin bulk drugs. Since then, the company has evolved into a composite pharmaceutical firm. In FY2003 the company clocked a turnover of $115mn, 80% of which was from exports, mostly to developing markets. The company’s promoters and affiliates own 17% of its equity, but the largest shareholder is Schroders, with 32.9%, followed by IFC with 10.9%.· Orchid’s first decade of operations ( 1994-2004) has been of intense challenge and achievement. Orchid is now set to be positioned on the global pharmaceutical map as a differential enterprise, with high-technology products, robust marketing alliances and international joint ventures. Several strategic initiatives of the past decade will now start yielding immense returns to the company in the next two years.· Orchid is one of the few pharmaceutical companies in India with a substantial programme of drug discovery. It has complete in-house infrastructure and capability, which can develop new drugs from in-silico design through synthesis, optimization and formulation and pre-clinical evaluation.· Two of Orchid’s manufacturing units (for sterile and oral cephalosporin bulk actives) have already been approved by the US FDA. New production units have also been commissioned, and US FDA inspections for these are expected in 2004. Orchid has also commissioned a formulations unit, which would cater to the US generics market. ANDA filings from this unit will begin in early 2004. We expect Orchid to file 15 ANDAs based on 10 molecules in the next 24 months, addressing a market worth $3bn. Similar filings are likely in Europe, and the products will be sold through alliances.TECHNICALs :· On the technical front, the stock has consolidated for almost three months between Rs.217 and Rs.245 and during this period the stock has witnessed volumes which none of the pharma stocks has seen in the past decade. This factor alone speaks volumes about the fact that bigger players are interested in this counter. Any positive announcement from the company will take the stock price into a new orbit.
|
|
#2
|
|||
|
|||
|
Good write up and call sh50.
Technically I would wait for the stock to close above 250.00-255.00. See attached chart. |
|
#3
|
|||
|
|||
|
I believe Natco Pharma or Aarti Drugs will be better bets.
|
|
#4
|
|||
|
|||
|
|
|
#5
|
|||
|
|||
|
Dear Traderji,
now orchid chemicals has closed above the trigeer price of Rs.255, i feel one can buy the stock. what could be the target and stoploss now. |
|
#6
|
|||
|
|||
|
Quote:
|
|
#7
|
|||
|
|||
|
Good Call. Orchid has finally broken out and closed above 295.Can anybody suggest the exit point and trailing stoploss.
|
|
#8
|
|||
|
|||
|
i believe orchid culd move intraday unless it cross 350 355' with sme gud volumes and market in positive also,. then we can see great rally in that stock
|
| Sponsored Links |
|
|
![]() |
| Bookmarks |
| Thread Tools | |
|
|
Similar Threads for: Orchid chemicals
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Thirumalai Chemicals | tanewbie | Investing on Fundamentals | 6 | 11th July 2005 07:31 PM |
| Orchid Chemicals | sbn021 | Equities | 3 | 20th January 2005 05:58 PM |
Indemnity, Disclaimer & Disclosure
Notice:
• By visiting Traderji.com you indicate your acceptance of our Forum
Rules Disclaimer & Disclosure and indemnify Traderji.com, its
associates and related parties of all claims howsoever resulting from
the usage of the forum.
• Disclaimer: Trading or investing in stocks & commodities
is a high risk activity. Any action you choose to take in the markets
is totally your own responsibility. Traderji.com will not be liable for
any, direct or indirect, consequential or incidental damages or loss arising out of the use of this information.
• Disclosure: The information in this forum is neither an offer to sell nor solicitation to buy any of the securities mentioned herein.
The writers may or may not be trading in the securities mentioned.
• All names or products mentioned are trademarks or registered trademarks of their respective owners.
General Content Disclaimer Notice:
In light of our policy of encouraging candid, open exchanges of views and the rapid distribution of information originating from many sources, Traderji.com cannot determine the accuracy of information that may be uploaded to the forum. Opinions, advice and all other information expressed by participants in discussions are those of the author. You rely on such information at your own risk. You are urged to seek professional advice for specific, individual situations and not rely solely on advice or opinions given in the discussions. Since Traderji.com is an open and free discussion forum, any comments made by members of this forum in their posts reflect their own views and not of the owner or administrator of Traderji.com. Thus the owner/administrator indemnify themselves of all claims whatsoever and will not be liable or responsible for any members comments/views in this forum Traderji.com. If you find any objectionable or offensive posts made by members of this forum which you would like to bring to our notice for removal then please Contact Us.